Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...

Even with prevention measures and timely, aggressive intervention, tumor lysis syndrome (TLS) remains life-threatening, as a ...

The Southern Christian Leadership Conference joined the father of 17-year old Jordan Davis on Friday to call for changes to Florida's "stand your ground" law. Jordan Davis was killed the day after ...

"Amgen’s Phase III trial of Imdelltra meets primary endpoint for SCLC" was originally created and published by Clinical ...

In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell lung cancer (SCLC).

The week marked several FDA approvals for drugs and devices, plus data continues to show tarlatamab’s benefit in small cell lung cancer.

Regulatory applications seeking approval for Imfinzi in LS-SCLC are currently under review in the EU, Japan and several other countries. Year to date, shares of AstraZeneca have decreased 0.9% ...

"This is the largest retrospective study to assess and demonstrate that immune-related toxicity is positively associated with improved clinical outcomes in patients with ES-SCLC [extensive-stage ...

David Spigel, MD, discusses the significant benefits of durvalumab as consolidation therapy following standard chemoradiotherapy for patients with limited-stage small cell lung cancer.